Extasy 09 (2006) «Updated»

: Research published in August 2006 confirmed that Merck did not initially market the drug for weight loss; it was essentially a chemical byproduct of other research into life-saving medicines. Medical and Scientific Context (2006)

The year 2006 was a pivotal time for scientific literature regarding the drug's long-term impact on the human body. Extasy 09 (2006)

: Contrary to the common myth that it was developed as an appetite suppressant, original documents from the German pharmaceutical company Merck revealed MDMA was first synthesized in 1912 . : Research published in August 2006 confirmed that

: Research published in late 2006 identified patterns of ecstasy-associated hyponatremia (dangerously low sodium levels), often occurring in female users. often occurring in female users.